Verily Impact Investors
Verily is an Alphabet precision health company that helps pharma and consumer health companies develop safe, effective treatments faster and enable patients, providers and payors to make better care decisions
Investors
Funding Status:
Private Equity
Headquarters:
South San Francisco, California, United States
Acquisitions Number:
Made Acquisitions
Founded Date:
2015-01-01
Employee Number:
1001-5000
Last Funding Type:
Secondary Market
Total Funding:
3500000000.0
Estimated Revenue:
$100M to $500M
Industry:
End-to-End Drug Development
Investors Number:
6
Last Funding Date:
2022-09-28
Number Of Exists:
4